IRCT2017020210417N6已完成未知
Evaluation of Direct-Acting Antiviral Regimens Effectiveness in Achieving Undetectable Viral Load in Chronic Hepatitis C Patients in Iran
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 90 years（—）
- 性别
- All
入选标准
- •Being diagnosed with hepatitis C and having a detectable viral count; Having not received any medications yet or being unresponsive to previous interferon-based treatments; Providing a freely signed consent form to be treated with new generic medications.
- •Exclusion criteria :Having a renal failure defined as eGFR
- •< 30 mL/min; Having a very advanced liver disease defined as MELD score > 20 or Child-Pugh score
- •> 12; Heart rate < 50 beats/min; History of previous treatment failure with sofosbuvir-based regimen; History of taking amiodarone within the last 6 months; Not consenting to participate in the study.
排除标准
- 未提供
研究者
相似试验
Enrolling By Invitation
不适用
Effectiveness and safety of direct acting antivirals for the management of patients with chronic hepatitis C virus in Thailand : A real-life multicenter study.1.End of treatment response (ETR) is the rate of treatment response. At the temple at the time of study discontinuance Which is divided into biochemical responses (with liver enzymes,ALT) and virologDAA.Chornic hepatitis C.TCTR20200313005one200
招募中
不适用
Antiviral therapy with direct acting anti-virals in hepatitis C patients.Chronic hepatitis CJPRN-UMIN000016288Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine500
已完成
3 期
Comparative study in childrens with chronic Hepatitis B virus infection who are HBeAg positive.CTRI/2011/09/002001The pharmaceutical company sponsoring this study is BristolMyers Squibb180
进行中（未招募）
1 期
A Comparative Study of the Antiviral Efficacy and Safety of Entecavir (ETV) versus Placebo in Pediatric Subjects with Chronic Hepatitis B Virus (HBV) Infection who are HBeAg-PositiveCHRONIC HEPATITIS B VIRUS,PEDIATRICMedDRA version: 12.1Level: LLTClassification code 10008910Term: Chronic hepatitis BEUCTR2009-016357-17-GRBristol-Myers Squibb International Corporation257
进行中（未招募）
不适用
A Comparative Study of the Antiviral Efficacy and Safety of Entecavir Plus Tenofovir versus Adefovir Added to Continuing Lamivudine in Adults with Lamivudine Resistant Chronic Hepatitis B Virus Infection. - NDHepatitis B VirusMedDRA version: 9.1Level: LLTClassification code 10008910Term: Chronic hepatitis BEUCTR2007-001269-14-ITBRISTOL-M.SQUIBB84